You are here

These Are The Top 5 Marijuana Stocks Of 2018 So Far

By Brandon A. Dorfman
May 15, 2018

Though 2018 is not quite to the halfway point yet, it is worth examining some of the better marijuana stocks from the first part of the year. While pot stocks have seen some volatility throughout the early part of 2018, these top picks have all managed to continue to strengthen their brand and their standing in the industry. And while cannabis stocks may be overvalued right now, intertest is still how in this growing sector.

Here are the top five marijuana stocks of 2018, so far:

Cronos Group Inc.

Cronos Group Inc. (NASDAQ:CRON) (TSX-V:CRON) made news this year when they became the first Canadian weed stock to list on the Nasdaq exchange. They are a diversified company with global holdings, operating two wholly-owned Canadian Licensed Producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations, Peace Naturals Project Inc., and Original BC Ltd.

What really put them over the top this year was when they recently announced a deal with Los Angeles based MedMen, one of the largest retailers of legal cannabis in the U.S. Together they created MedMen Canada Inc., a joint partnership split evenly down the middle that will bring the MedMen brand into Canada via new products and retail stores.

Aphria Inc.

At first glance, this struggling company does not seem like a top pick, after all, Aphria Inc. (TSX:APH) (USOTC:APHQF) is a company that just cannot seem to catch a break. However, when they announced this year that the recently acquired Nuuvera Inc. would be renamed Aphria International Inc. and remain a wholly-owned subsidiary of the company, it piqued the interest of many investors. This new entity will focus on the international market, looking at legalized cannabis in Germany, Italy, Spain, Portugal, Malta, Australia and Lesotho.  

The move towards international markets should keep them churning away as one of the industry’s top companies. Even more, it is hard to see how a company as well run as Aphria could continue to have such bad luck.

CannaRoyalty Corp.

CannaRoyalty Corp. (CSE:CRZ) (OTCQX:CNNRF) is without a doubt the most diversified pot stock on the market today. They have numerous holdings across the United States and Canada. But, it is the company’s focus on the California market this year that makes them one of 2018’s best picks. It is a smart move, as the West Coast state is a larger market than the whole of Canada. Recent acquisitions of River Corp. and Kaya and Alta Supply show the company’s dealmaking strength making this weed stock one of 2018’s top buys in an otherwise down market.

Scotts Miracle-Gro Company

The Scotts Miracle-Gro Co. (NYSE:SMG) is a household name in garden materials whose move towards cannabis made them a top-rated marijuana stock pick. They have a 75 percent stake in hydroponics equipment company Gavita International, and with that sector set to grow to $24 billion this year alone, it makes this company one of 2018’s best marijuana stock picks. They claim revenues of upwards of $250 million per year from hydroponics, and, most notably, they pay a 2.16 percent dividend yield. They have grown their dividend for the past seven years consistently. One of the best pot stocks of 2018, this household name turned marijuana stock may be the safest bet yet during the pot stock downturn.

Isodiol International Inc.

Global Bioactive CBD oil company Isodiol International Inc. (CSE:ISOL) (ISOLF) announced this year the acquisition of several global assets, making them one of 2018’s top marijuana stocks in the industry. The company has begun to develop a new facility in China where they plan to take certified organic hemp and extract cannabinoids and terpenes.

Isodiol’s new strategic assets in the U.K., Brazil, and China may help the company attain global dominance in the growing CBD oil sector. In fact, as once noted on this site, they are, “a pot stock so steeped in extracts that CBD oil stock seems the more appropriate term.”

“These transactions mark major milestones for Isodiol. The acquisitions ensure the company has a continued source of CBD and scalability of production as our international expansion continues to generate additional market demand for our products,” remarked CEO Marcos Agramont. Isodiol is making some of the best moves in the market today.

Related Companies

Share this article